COMBINATION THERAPY FOR TREATING CANCER
The disclosure relates to a method for treatment of cancer comprising administering to a subject in need thereof a first agent in a therapeutically effective amount and a second agent in a therapeutically effective amount. Preferably, the first agent comprises an EZH2 inhibitor, e.g., tazemetostat o...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
03.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure relates to a method for treatment of cancer comprising administering to a subject in need thereof a first agent in a therapeutically effective amount and a second agent in a therapeutically effective amount. Preferably, the first agent comprises an EZH2 inhibitor, e.g., tazemetostat or a pharmaceutically acceptable salt thereof. In certain embodiments, the methods of the disclosure are used to treat breast cancer, ovarian cancer, or both. |
---|---|
Bibliography: | Application Number: AU20220252738 |